DK0673368T3 - Hidtil ukendte nicotinsyreestere - Google Patents

Hidtil ukendte nicotinsyreestere

Info

Publication number
DK0673368T3
DK0673368T3 DK93915075T DK93915075T DK0673368T3 DK 0673368 T3 DK0673368 T3 DK 0673368T3 DK 93915075 T DK93915075 T DK 93915075T DK 93915075 T DK93915075 T DK 93915075T DK 0673368 T3 DK0673368 T3 DK 0673368T3
Authority
DK
Denmark
Prior art keywords
saturated
carbon atoms
hitherto unknown
compounds
nicotinic esters
Prior art date
Application number
DK93915075T
Other languages
English (en)
Inventor
Goeran Martens Vaeg Pettersson
Anders Bjoerk
Lisbeth Abramo
Curt Nordvi
Torbjoern Lundstedt
Gunnar Andersson
Wu Jin Chang
Catarina Ludwig
Elisabeth Seifert
Arne Nilsson
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Application granted granted Critical
Publication of DK0673368T3 publication Critical patent/DK0673368T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK93915075T 1992-06-25 1993-06-23 Hidtil ukendte nicotinsyreestere DK0673368T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9201956A SE9201956D0 (sv) 1992-06-25 1992-06-25 Novel nicotinicacid esters
PCT/SE1993/000565 WO1994000434A1 (en) 1992-06-25 1993-06-23 Novel nicotinic acid esters

Publications (1)

Publication Number Publication Date
DK0673368T3 true DK0673368T3 (da) 2002-03-18

Family

ID=20386602

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93915075T DK0673368T3 (da) 1992-06-25 1993-06-23 Hidtil ukendte nicotinsyreestere

Country Status (27)

Country Link
US (1) US5658910A (da)
EP (2) EP0673368B1 (da)
JP (1) JP3306827B2 (da)
KR (1) KR100302216B1 (da)
CN (1) CN1085981C (da)
AT (2) ATE209634T1 (da)
AU (1) AU681346B2 (da)
BG (1) BG62000B1 (da)
CA (1) CA2139112C (da)
CZ (1) CZ281975B6 (da)
DE (2) DE69331234T2 (da)
DK (1) DK0673368T3 (da)
EE (1) EE03122B1 (da)
ES (1) ES2169044T3 (da)
FI (1) FI107151B (da)
HU (2) HU220613B1 (da)
IL (1) IL106135A (da)
NO (1) NO302945B1 (da)
NZ (1) NZ253823A (da)
PH (1) PH31417A (da)
PT (1) PT673368E (da)
RO (1) RO115725B1 (da)
RU (1) RU2127732C1 (da)
SE (1) SE9201956D0 (da)
SK (1) SK279393B6 (da)
WO (1) WO1994000434A1 (da)
ZA (1) ZA934596B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632823B1 (en) * 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
EP1087963B1 (en) 1998-06-19 2004-08-25 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US7045519B2 (en) * 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
UA126099C2 (uk) * 2018-05-09 2022-08-10 ЕлДжи КЕМ, ЛТД. Сполука, яка виявляє інгібувальну активність відносно ентеропептидази

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
SE9201239D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Agents for treating substance abuse disorders
SE9202265D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel- pyridyl and pyrimidylpiperazine derivatives

Also Published As

Publication number Publication date
CA2139112C (en) 2006-03-21
ATE209634T1 (de) 2001-12-15
PH31417A (en) 1998-10-29
ES2169044T3 (es) 2002-07-01
DE69331234D1 (de) 2002-01-10
FI946085A (fi) 1994-12-23
PT673368E (pt) 2002-05-31
CN1085981C (zh) 2002-06-05
FI107151B (fi) 2001-06-15
HU220613B1 (hu) 2002-03-28
SK158594A3 (en) 1995-07-11
JPH07508517A (ja) 1995-09-21
EP1120410B1 (en) 2004-10-06
CN1086811A (zh) 1994-05-18
CZ281975B6 (cs) 1997-04-16
WO1994000434A1 (en) 1994-01-06
AU681346B2 (en) 1997-08-28
KR950702186A (ko) 1995-06-19
IL106135A (en) 1999-01-26
JP3306827B2 (ja) 2002-07-24
HU210875A9 (en) 1995-08-28
SK279393B6 (sk) 1998-11-04
SE9201956D0 (sv) 1992-06-25
CZ327494A3 (en) 1995-09-13
NO945022D0 (no) 1994-12-23
KR100302216B1 (ko) 2001-11-22
AU4519393A (en) 1994-01-24
CA2139112A1 (en) 1994-01-06
RU94046310A (ru) 1996-10-27
BG99289A (bg) 1995-09-29
NO945022L (no) 1995-02-13
EP1120410A1 (en) 2001-08-01
EP0673368B1 (en) 2001-11-28
ZA934596B (en) 1994-02-14
DE69331234T2 (de) 2002-08-08
EP0673368A1 (en) 1995-09-27
HUT71406A (en) 1995-11-28
NO302945B1 (no) 1998-05-11
EE03122B1 (et) 1998-10-15
DE69333655D1 (de) 2004-11-11
BG62000B1 (bg) 1998-12-30
ATE278671T1 (de) 2004-10-15
NZ253823A (en) 1996-01-26
RO115725B1 (ro) 2000-05-30
HU9403786D0 (en) 1995-02-28
RU2127732C1 (ru) 1999-03-20
IL106135A0 (en) 1993-10-20
US5658910A (en) 1997-08-19
FI946085A0 (fi) 1994-12-23

Similar Documents

Publication Publication Date Title
BG105254A (en) Heterocyclic compounds as inhibitors of rotamase enzymes
MX166257B (es) Composicion de revestimiento que contiene grupos de carbamato de hidroxialquilo
DE69133299D1 (de) Aminosulfonylcarbamate
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
DE3474444D1 (en) 1,3,4,5-tetrahydrobenzo(c,d)indoles, process for their preparation and their uses
GB1464583A (en) Preparation of quinazoline derivatives
DK0673368T3 (da) Hidtil ukendte nicotinsyreestere
ATE194982T1 (de) Benzoxazepin-derivate als cholinesterase- inhibitoren
FI940731A0 (fi) Amiditetratsolit ACAT-inhibiitoreina
ATE218538T1 (de) Azahexan-derivate als substratisostere von retroviralen aspartat-proteasen
MX170732B (es) Composicion de derivados de succinimida y su uso
ATE140229T1 (de) Benzoxazepinon-verfahren
DE3867652D1 (de) N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.
DE69329281D1 (de) Pyridinderivate als Hydroxylase- und Lyase-Inhibitoren
ES2140552T3 (es) Derivados indol como inhibidores de la 5-alfa-reductasa-1.
ATE30415T1 (de) Enkephalinas-inhibitoren.
NO179004C (no) Analogifremgangsmåte til fremstilling av terapeutisk aktive imidazolderivater
ATE93850T1 (de) Monopersulfate von stickstoffenthaltenden heterocyclischen polypercarbonsaeuren.
GEP19971013B (en) Novel pyridyl and pyrimidyl derivatives process for preparing thereof, and treatment method for mental disorder
GB1212368A (en) Substituted s-triazines